Literature DB >> 26853723

Trans-presentation of interleukin-15 by interleukin-15 receptor alpha is dispensable for the pathogenesis of autoimmune type 1 diabetes.

Diwakar Bobbala1, Marian Mayhue1, Alfredo Menendez2,3, Subburaj Ilangumaran1,3, Sheela Ramanathan1,3.   

Abstract

Interleukin-15 (IL-15) is a pro-inflammatory cytokine that is required for the survival and activation of memory CD8+T cells, natural killer (NK) cells, innate lymphoid cells, macrophages and dendritic cells. IL-15 is implicated in the pathogenesis of various autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, psoriasis and autoimmune type 1 diabetes (T1D). IL-15 receptor (IL-15R) consists of a specific α chain, the β chain that is shared with IL-2R and the common γ chain. IL-15 is unique in the manner in which it binds and signals through its receptor subunits. IL-15 that is complexed with IL-15Rα binds to the βγ receptor complex present on the responding cell to mediate its biological effects through a process referred to as trans-presentation. The trans-presented IL-15 is essential to mediate the biological effects on T lymphocytes and NK cells. Here we show that IL-15, but not IL-15Rα, is required for the development of spontaneous and virus-induced T1D, viral clearance and for antigen cross-presentation to CD8+ T lymphocytes. Our findings provide insight into the complexities of IL-15 signalling in the initiation and maintenance of CD8+ T cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26853723      PMCID: PMC5520411          DOI: 10.1038/cmi.2015.102

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  37 in total

1.  Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha.

Authors:  E John Wherry; Todd C Becker; David Boone; Murali-Krishna Kaja; Averil Ma; Rafi Ahmed
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

Review 2.  Lessons on autoimmune diabetes from animal models.

Authors:  Yang Yang; Pere Santamaria
Journal:  Clin Sci (Lond)       Date:  2006-06       Impact factor: 6.124

3.  Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo.

Authors:  Guangwei Cui; Takahiro Hara; Szandor Simmons; Keisuke Wagatsuma; Akifumi Abe; Hitoshi Miyachi; Satsuki Kitano; Masaru Ishii; Shizue Tani-ichi; Koichi Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

4.  Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.

Authors:  Vanja Lazarevic; David J Yankura; Sherrie J DiVito; JoAnne L Flynn
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Cutting edge: the role of IFN-α receptor and MyD88 signaling in induction of IL-15 expression in vivo.

Authors:  Sara L Colpitts; Thomas A Stoklasek; Courtney R Plumlee; Joshua J Obar; Caiying Guo; Leo Lefrançois
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

6.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

7.  IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite.

Authors:  Rajarshi Bhadra; Imtiaz A Khan
Journal:  Microbes Infect       Date:  2012-08-01       Impact factor: 2.700

8.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

9.  Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells.

Authors:  Todd C Becker; E John Wherry; David Boone; Kaja Murali-Krishna; Rustom Antia; Averil Ma; Rafi Ahmed
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

10.  T cell-independent interleukin 15Ralpha signals are required for bystander proliferation.

Authors:  J P Lodolce; P R Burkett; D L Boone; M Chien; A Ma
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

View more
  5 in total

1.  Bisphenol A alteration of type 1 diabetes in non-obese diabetic (NOD) female mice is dependent on window of exposure.

Authors:  Joella Xu; Guannan Huang; Tamas Nagy; Tai L Guo
Journal:  Arch Toxicol       Date:  2019-03-02       Impact factor: 5.153

Review 2.  Developmental and Functional Control of Natural Killer Cells by Cytokines.

Authors:  Yang Wu; Zhigang Tian; Haiming Wei
Journal:  Front Immunol       Date:  2017-08-04       Impact factor: 7.561

3.  Investigation of Immune-Regulatory Effects of Mageumsan Hot Spring via Protein Microarray In Vitro.

Authors:  Hyung Jin Hahn; Jung Soo Kim; Yeong Ho Kim; Young Bok Lee; Dong Soo Yu; Jin-Wou Kim
Journal:  Ann Dermatol       Date:  2018-04-23       Impact factor: 1.444

4.  Deficiency of Interleukin-15 Confers Resistance to Obesity by Diminishing Inflammation and Enhancing the Thermogenic Function of Adipose Tissues.

Authors:  Gregory Lacraz; Volatiana Rakotoarivelo; Sebastien M Labbé; Mathieu Vernier; Christophe Noll; Marian Mayhue; Jana Stankova; Adel Schwertani; Guillaume Grenier; André Carpentier; Denis Richard; Gerardo Ferbeyre; Julie Fradette; Marek Rola-Pleszczynski; Alfredo Menendez; Marie-France Langlois; Subburaj Ilangumaran; Sheela Ramanathan
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

5.  IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of Listeria monocytogenes.

Authors:  Madhuparna Nandi; Mitterrand Muamba Moyo; Sakina Orkhis; Jeanne Masunga Faida Mobulakani; Marc-André Limoges; Fjolla Rexhepi; Marian Mayhue; Anny Armas Cayarga; Gisela Cofino Marrero; Subburaj Ilangumaran; Alfredo Menendez; Sheela Ramanathan
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.